Merck to support manufacturing of Johnson & Johnson’s Covid-19 vaccine
Merck (MSD) has signed an agreement with Janssen Pharmaceuticals (JPI), one of the Janssen Pharmaceutical Companies of Johnson & Johnson,…
03 Mar 2021
US court rules in favour of AstraZeneca in Symbicort patent litigation
A US district court for the Northern District of West Virginia has decided in favour of AstraZeneca in a patent litigation lawsuit against Mylan Pharmaceuticals, which is now part of…
03 Mar 2021
ObvioHealth and RedHill to begin remote Covid-19 therapy trial
ObvioHealth is set to initiate a Phase II/III study of RedHill Biopharma’s RHB-107 (upamostat) in the US for Covid-19 treatment. ObvioHealth will use its clinical trial ecosystem for the trial,…
03 Mar 2021
NIH pauses Covid-19 convalescent plasma trial
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as the study provided no significant…
03 Mar 2021
WuXi AppTec strengthens gene therapy offerings with OXGENE acquisition
WuXi AppTec has concluded the acquisition of UK-based contract research and development organisation OXGENE to boost its cell and gene therapy services for customers worldwide. OXGENE will now be a…
03 Mar 2021
Cerecor’s antibody reduces respiratory failure in Covid-19 ARDS trial
Cerecor has reported that final efficacy data from Phase II trial of human anti-LIGHT (TNFSF14) monoclonal antibody, CERC-002, in hospitalised patients with Covid-19 linked pneumonia and mild-to-moderate acute respiratory distress…
02 Mar 2021
CRUK teams up with Teon to trial first-in-class cancer drug
Cancer Research UK (CRUK) has signed a clinical development collaboration with California-based Teon Therapeutics. Teon’s work focuses on developing a portfolio of immunotherapies for cancer that modulates and antagonises metabolic…